KOSDAQ-listed firms grapple with falling profits

The combined sales revenue of the 14 KOSDAQ-listed pharmaceutical firms last year marked a growth rate of 8 percent to 431.3 billion won, up 8.3 percent compared with 398.0 billion won from a year earlier but their operating profit and net income plunged 7.9 percent to 65.8 billion won and 24.2 percent to 32.6 billion won, respectively, according to a survey conducted by Yakup Shinmoon, a local...